8-K - ONMD - Equibles

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM

8-K

CURRENT

REPORT

Pursuant

to Section 13 or 15(d) of

the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 3, 2024

ONEMEDNET

CORPORATION

(Exact name of registrant as specified in its charter)

Delaware	001-40386	86-2076743
(State<br> or other jurisdiction<br><br> <br>of<br> incorporation)	(Commission<br><br> <br>File<br> Number)	(I.R.S.<br> Employer<br><br> <br>Identification<br> Number)

6385Old Shady Oak Road, Suite 250

EdenPrairie, MN 55344

(Address of principal executive offices) (Zip Code)

Registrant’s

telephone number, including area code: 800-918-7189

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written<br> communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting<br> material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement<br> communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement<br> communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol(s)	Name of Each Exchange on Which Registered
Class<br> A Common Stock, $0.0001 par value per share	ONMD	The<br> Nasdaq Stock Market LLC
Redeemable<br> Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share	ONMDW	The<br> Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Section4 – Matters Related to Accountants and Financial Statements

Item4.01 Changes in Registrant’s Certifying Accountant

Appointmentof Independent Registered Public Accounting Firm

As previously reported on Form 8-K by OneMedNet Corporation (the “Company”) on May 10, 2024, on May 6, 2024, the Company dismissed BF Borgers CPA PC (“Borgers”) as its independent registered public accounting firm following the Securities and Exchange Commission (the “SEC”) announcement that it had settled charges against Borgers that it failed to conduct audits of a number of public companies in accordance with the standards of the Public Company Accounting Oversight Board (the “PCAOB”) on May 3, 2024. As part of the settlement, Borgers agreed to a permanent ban on appearing or practicing before the SEC (the “Order”).

On June 3, 2024, the Company appointed WithumSmith+Brown, PC (“WS+B”) as its new independent registered public accounting firm to audit and review the Company’s financial statements. During the two most recent fiscal years ended December 31, 2023 and 2022 and any subsequent interim periods through the date hereof prior to the engagement of WS+B, neither the Company, nor someone on its behalf, has consulted WS+B regarding:

(i)	either:<br> the application of accounting principles to a specified transaction, either completed or proposed; or the type of audit opinion that<br> might be rendered on the Company’s consolidated financial statements, and either a written report was provided to the Company<br> or oral advice was provided that the new independent registered public accounting firm concluded was an important factor considered<br> by the Company in reaching a decision as to the accounting, auditing or financial reporting issue; or
(ii)	any<br> matter that was either the subject of a disagreement as defined in paragraph 304(a)(1)(iv) of Regulation S-K or a reportable event<br> as described in paragraph 304(a)(1)(v) of Regulation S-K.

Item4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.

(a) At this time, the Company is not aware of any basis to believe that any previously issued financial statements should not be relied upon because of an error in such financial statements. However, the Company continues to assess its financial statements in light of the events described in Item 4.01(a) herein.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ONEMEDNET CORPORATION
Date:<br> June 4, 2024
	By:	/s/ Aaron Green
	Name:	Aaron<br> Green
	Title:	Chief<br> Executive Officer